Advertisement

Topics

Bay Area's Tricida Closes $57.5M Series D, Pushes Into Phase III Trial

19:00 EST 7 Nov 2017 | BioSpace

Proceeds will be used to complete the ongoing pivotal TRCA-301 Phase 3 clinical trial of TRC101.

Original Article: Bay Area's Tricida Closes $57.5M Series D, Pushes Into Phase III Trial

NEXT ARTICLE

More From BioPortfolio on "Bay Area's Tricida Closes $57.5M Series D, Pushes Into Phase III Trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...